No published results from the one Phase II trial that was actually conducted
Application of the CaM kinase inhibitor KN93 impaired the action of glutamine, glucose and alanine, suggesting that it acts at a common step in the secretory pathway
Insufficient/not enough sleep and stress are key dysregulators of weight, insulin sensitivity and inflammation in the body, all things we are trying to optimize with GLPs
Wegovy and Mounjaro are currently the safest and most effective approved options
By addressing these common concerns and implementing the right strategies, we can work together towards achieving your weight loss goals with semaglutide
Each patient receives enough time to describe their challenges, goals, and previous attempts, and this information becomes the foundation for a personalized treatment plan